Enhanced Implantable Drug Delivery System for Opioid Overdose Treatment

Publication ID: 24-11857758_0006_PTD
Published: November 07, 2025
Category:Direct Improvements & Enhancements

Legal Citation

pr1or.art Inc., “Enhanced Implantable Drug Delivery System for Opioid Overdose Treatment,” Published Technical Disclosure No. 24-11857758_0006_PTD, Published November 07, 2025, available at https://archive.pr1or.art/24-11857758_0006_PTD
This technical disclosure describes improvements that would be readily apparent to a Person Having Ordinary Skill In The Art (PHOSITA) when considered in combination with the foundational architecture disclosed in U.S. Patent No. 11,857,758.

Summary of the Inventive Concept

The present inventive concept discloses an improved implantable drug delivery system that addresses the limitations of existing single-use devices, providing a sustained release of medication over an extended period, customizable treatment options, and enhanced safety features for opioid overdose treatment.

Background and Problem Solved

The original patent disclosed a single-use implantable drug delivery device for treating opioid overdoses. However, this device has limitations, including the inability to provide sustained release of medication, limited customization options, and potential overheating issues. The present inventive concept addresses these limitations by introducing a system of multiple devices, customizable treatment options, and safety features to enhance the effectiveness and safety of opioid overdose treatment.

Detailed Description of the Inventive Concept

The enhanced implantable drug delivery system comprises a plurality of devices, each with a housing, reservoir, and temporary seal. The devices are designed to be triggered in a staggered manner, providing a sustained release of medication over an extended period. The system also includes a wearable device for detecting physiological reactions to an opioid overdose, which communicates with the implantable device to trigger the delivery of medication. Additionally, the device includes a cooling mechanism to prevent overheating and customizable settings based on an individual's physiological response to an opioid overdose.

Novelty and Inventive Step

The present inventive concept introduces a novel system of multiple devices, customizable treatment options, and safety features that overcome the limitations of existing single-use devices. The staggered triggering of devices, wearable detection device, and cooling mechanism are new and non-obvious features that enhance the effectiveness and safety of opioid overdose treatment.

Alternative Embodiments and Variations

Alternative embodiments of the inventive concept could include varying the number and configuration of devices, using different types of sensors or detection mechanisms, or incorporating additional safety features such as automatic shutdown or alert systems. Variations could also include adapting the system for use with different types of medications or treating other medical conditions.

Potential Commercial Applications and Market

The enhanced implantable drug delivery system has significant commercial potential in the medical device industry, particularly in the treatment of opioid overdoses. The system's customizable treatment options, sustained release of medication, and enhanced safety features make it an attractive solution for healthcare providers, patients, and caregivers. The market for opioid overdose treatment devices is growing rapidly, and this inventive concept is well-positioned to capture a significant share of this market.

CPC Classifications

SectionClassGroup
A A61 A61M5/14276
A A61 A61B5/4839
A A61 A61B5/4845
A A61 A61B5/4848
A A61 A61K9/0024
A A61 A61K9/0097
A A61 A61M5/44
A A61 A61M31/002
A A61 A61M37/0069
A A61 A61B5/01
A A61 A61F2250/0068
A A61 A61K31/485

Original Patent Information

Patent NumberUS 11,857,758
TitleDrug delivery device and method
Assignee(s)Purdue Research Foundation